China Yongxin Pharmaceuticals, Inc. (fka CYXN)

[BiotechValues]

CGDI "sells a lot of shares" ???

Do you have links to demonstrate that?

Management owns 31 million of the O/S 35 million shares.These shares are restricted until 5/08/2010 and can not be sold.

There have been NO INSIDER SALES, and minimal dilution of their shares since the reverse merger was completed last year.
Share count in latest filing on page 2.
http://yahoo.brand.edgar-online.com/displayfilinginfo.aspx?FilingID=6260517-1100-89734&type=sect&TabIndex=2&companyid=598161&ppu=%252fdefault.aspx%253fcik%253d1217021

The value of CGDI's commercial holdings is reported to the SEC as $66,000,000. With only about $35,000,000 shares outstanding (and trading float under 3M shares), the value/share of their commercial real estate is $1.89.

Put it this way, if CGDI were to stop all operations tomorrow, pay off all debt, sell their properties, and distribute cash to shareholders, shareholders would get well over $1/share back.

THAT is how undervalued the company is....and yet they're trading at a PE of under 1 (like CYXN was a few weeks ago).
When they report annual numbers next week, the stock will move.